Literature DB >> 10476318

Complications of allergic rhinitis.

R A Settipane1.   

Abstract

With unfortunate high frequency, clinicians consider allergic rhinitis to be more of a nuisance than an illness. When in fact, allergic rhinitis is not only a very common disease process, affecting up to a cumulative frequency of 42% of the U.S. population by age 40, but can lead to significant short-term and long-term medical complications. Poorly controlled symptoms of allergic rhinitis may contribute to sleep loss, secondary daytime fatigue, learning impairment, decreased overall cognitive functioning, decreased long-term productivity and decreased quality of life. Additionally, poorly controlled allergic rhinitis may also contribute to the development of other related disease processes including acute and chronic sinusitis, recurrence of nasal polyps, otitis media/otitis media with effusion, hearing impairment, abnormal craniofacial development, sleep apnea and related complications, aggravation of underlying asthma, and increased propensity to develop asthma. Treatment of allergic rhinitis with sedating antihistamine therapy may result in negative neuropsychiatric effects that contribute to some of these complications. Sedating antihistamines may also be dangerous to use in certain other settings such as driving or operating potentially dangerous machinery. In contrast nonsedating antihistamines have been demonstrated to result in improved performance in allergic rhinitis.

Entities:  

Mesh:

Year:  1999        PMID: 10476318     DOI: 10.2500/108854199778339053

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  10 in total

Review 1.  The safety and efficacy of desloratadine for the management of allergic disease.

Authors:  William E Berger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments.

Authors:  Glenis Scadding
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 3.  Prevalence and differential diagnosis of chronic rhinitis.

Authors:  J W Georgitis
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.806

4.  Non-interventional study comparing treatment satisfaction in patients treated with antihistamines.

Authors:  Christine De Vos; Krassimir Mitchev; Marie-Etienne Pinelli; Marie-Paule Derde; Rossen Boev
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

5.  Nasal steroid perspective: knowledge and attitudes.

Authors:  Cemal Cingi; Murat Songu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-21       Impact factor: 2.503

Review 6.  Safety and tolerability of treatments for allergic rhinitis in children.

Authors:  Carlos E Baena-Cagnani
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 7.  Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Authors:  Anjuli Nayak; Ronald B Langdon
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Attention Deficit Disorder and Allergic Rhinitis: Are They Related?

Authors:  Isaac Melamed; Melinda Heffron
Journal:  J Immunol Res       Date:  2016-10-31       Impact factor: 4.818

9.  Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey.

Authors:  Leonard M Fromer; Gabriel R Ortiz; April M Dowdee
Journal:  World Allergy Organ J       Date:  2008-09       Impact factor: 4.084

10.  Influence of chronic sinusitis and nasal polyp on the lower airway of subjects without lower airway diseases.

Authors:  Suh-Young Lee; Soon Ho Yoon; Woo-Jung Song; So-Hee Lee; Hye-Ryun Kang; Sun-Sin Kim; Sang-Heon Cho
Journal:  Allergy Asthma Immunol Res       Date:  2014-03-21       Impact factor: 5.764

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.